Diagnosis of Alzheimer's becoming more common, but less severe

June 26, 2018, Duke University
Credit: Duke University

Alzheimer's disease is the most common form of dementia, affecting nearly six million Americans. Aside from the incredible toll it takes on patients and their families, the estimated total cost of care is over $400 billion. As the baby boomer generation continues to age, this economic, physical, and emotional burden is only expected to increase. In the fight against Alzheimer's, it's crucial that policymakers, researchers, scientists, and physicians are armed with forecasts based on accurate assessments of this disease.

Recently, population health scientists have described Alzheimer's as both decreasing and increasing in prevalence. This confusion may stem from the difficulty in making a definitive diagnosis. The lack of standardization in identifying patients in the data can also cause different study results.

To better understand the direction of current trends in Alzheimer's disease and other dementias, researchers from the Biodemography of Aging Unit at the Social Science Research Institute analyzed individual medical records and results of cognitive assessments commonly used to determine drawn from the Health and Retirement Study data.

"An important advantage [of the study] is that it's one of the few large, nationally representative datasets to provide both repeated measurements on an individuals' cognitive status and information on diagnoses made by medical professionals through the Medicare system," said Igor Akushevich, associate research professor in the Social Science Research Institute and member of the Biodemography of Aging Unit at SSRI.

"We found that although the prevalence of Alzheimer's disease diagnoses in the Medicare population is increasing, the level of cognitive impairment in these very same individuals has been going down. This is good news and while more research is required before we can make a definitive conclusion, it likely suggests that doctors are identifying the disease at increasingly earlier stages," he said.

Researchers also identified the need for care when using pre-defined thresholds for classifying a cognitive impairment test result as .

"We found that if you use a slightly different threshold, then you get a very different estimate of the trend in dementia. These estimates are very sensitive to the specific value of the threshold," Akushevich said.

The findings are in keeping with some major population trends, like the aging Baby Boomer population that's estimated at around 70 or 80 million depending on what year is used to define the generation's origin.

With Baby Boomers reaching retirement and old age, more diagnoses of age-related dementia can be expected. At the same time, these diagnoses are becoming less severe and represent less of a burden on the patient, caregivers, and health system.

"We don't have a lot of definitive knowledge about Alzheimer's disease, its biology, or the reasons for its development and progression. We've studied this condition for a very long time, but it's proving a difficult nut to crack," Akushevich said.

Because researchers know that age groups are affected differently by cognitive impairment, future work will include a thorough analysis of the age structure of the disease.

The Biodemography of Aging Unit at SSRI hosts many experts in genetics, so future research will also clarify the role of genetics in the development of Alzheimer's and other related dementias.

Explore further: Population of Americans with Alzheimer's will more than double by 2060, study shows

More information: A public resource for data on aging in America since 1990. hrsonline.isr.umich.edu/

Related Stories

Population of Americans with Alzheimer's will more than double by 2060, study shows

December 7, 2017
About 15 million Americans will have either Alzheimer's dementia or mild cognitive impairment by 2060, up from approximately 6.08 million this year, according to a new study by researchers at the UCLA Fielding School of Public ...

New forecast shows 6 million with Alzheimer's disease, cognitive impairment

December 8, 2017
Using new methodology, scientists calculate that approximately 6 million American adults have Alzheimer's disease or mild cognitive impairment, which can sometimes be a precursor to the disease. The estimate, funded by the ...

Older adults are increasingly identifying—but still likely underestimating—cognitive impairment

January 16, 2018
An increasing number of older adults are reporting cognitive impairment in their families over the past two decades, according to a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's ...

Alzheimer's proteins in ICU survivors

March 29, 2018
While modern medicine has increased the number of people who survive a stay in the Intensive Care Unit (ICU), survivors have a high risk of developing problems with thinking and memory, a phenomenon called cognitive impairment.

Impact of Medicare annual wellness visit on detection of cognitive impairment is minimal

April 10, 2018
In the first nationwide study to measure the effect of the Medicare Annual Wellness Visit on early identification of cognitive impairment such as Alzheimer's disease, researchers from the Indiana University Center for Aging ...

New guideline: Try exercise to improve memory, thinking

December 27, 2017
For patients with mild cognitive impairment, don't be surprised if your health care provider prescribes exercise rather than medication. A new guideline for medical practitioners says they should recommend twice-weekly exercise ...

Recommended for you

New discoveries predict ability to forecast dementia from single molecule

December 11, 2018
Scientists who recently identified the molecular start of Alzheimer's disease have used that finding to determine that it should be possible to forecast which type of dementia will develop over time—a form of personalized ...

Researchers classify Alzheimer's patients in six subgroups

December 5, 2018
Researchers studying Alzheimer's disease have created an approach to classify patients with Alzheimer's disease, a finding that may open the door for personalized treatments.

Neuroscientists pinpoint genes tied to dementia

December 3, 2018
A UCLA-led research team has identified genetic processes involved in the neurodegeneration that occurs in dementia—an important step on the path toward developing therapies that could slow or halt the course of the disease. ...

Detecting signs of neurodegeneration earlier and more accurately

November 30, 2018
Signs of neurodegenerative diseases, appearing years before the emergence of clinical manifestations, can be detected during the examination of medical samples by means of fluorescence microscopy by using new sensitive and ...

Never-before-seen DNA recombination in the brain linked to Alzheimer's disease

November 21, 2018
Scientists from Sanford Burnham Prebys Medical Discovery Institute (SBP) have identified gene recombination in neurons that produces thousands of new gene variants within Alzheimer's disease brains. The study, published today ...

New information on the pathological mechanisms of Alzheimer's disease

November 21, 2018
Researchers at the University of Helsinki have discovered a mechanism by which harmful tau protein aggregates are transmitted between neurons. Alongside amyloid plaques, tau aggregates in the brain are a significant factor ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.